These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of cisplatin resistance. Mueller T; Mueller LP; Luetzkendorf J; Voigt W; Simon H; Schmoll HJ Tumour Biol; 2006; 27(2):71-83. PubMed ID: 16557044 [TBL] [Abstract][Full Text] [Related]
5. Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours. Rudolph C; Melau C; Nielsen JE; Vile Jensen K; Liu D; Pena-Diaz J; Rajpert-De Meyts E; Rasmussen LJ; Jørgensen A Cell Oncol (Dordr); 2017 Aug; 40(4):341-355. PubMed ID: 28536927 [TBL] [Abstract][Full Text] [Related]
6. Reduced proficiency in homologous recombination underlies the high sensitivity of embryonal carcinoma testicular germ cell tumors to Cisplatin and poly (adp-ribose) polymerase inhibition. Cavallo F; Graziani G; Antinozzi C; Feldman DR; Houldsworth J; Bosl GJ; Chaganti RS; Moynahan ME; Jasin M; Barchi M PLoS One; 2012; 7(12):e51563. PubMed ID: 23251575 [TBL] [Abstract][Full Text] [Related]
7. The bromodomain inhibitor JQ1 triggers growth arrest and apoptosis in testicular germ cell tumours in vitro and in vivo. Jostes S; Nettersheim D; Fellermeyer M; Schneider S; Hafezi F; Honecker F; Schumacher V; Geyer M; Kristiansen G; Schorle H J Cell Mol Med; 2017 Jul; 21(7):1300-1314. PubMed ID: 28026145 [TBL] [Abstract][Full Text] [Related]
8. NANOG controls testicular germ cell tumour stemness through regulation of MIR9-2. Cardenas RP; Zyoud A; McIntyre A; Alberio R; Mongan NP; Allegrucci C Stem Cell Res Ther; 2024 May; 15(1):128. PubMed ID: 38693576 [TBL] [Abstract][Full Text] [Related]
9. Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours. Roška J; Lobo J; Ivovič D; Wachsmannová L; Mueller T; Henrique R; Jerónimo C; Chovanec M; Jurkovičová D Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768818 [TBL] [Abstract][Full Text] [Related]
10. Testicular germ cell tumours: the paradigm of chemo-sensitive solid tumours. di Pietro A; Vries EG; Gietema JA; Spierings DC; de Jong S Int J Biochem Cell Biol; 2005 Dec; 37(12):2437-56. PubMed ID: 16099193 [TBL] [Abstract][Full Text] [Related]
11. Influence of vitamin D on cisplatin sensitivity in testicular germ cell cancer-derived cell lines and in a NTera2 xenograft model. Jørgensen A; Blomberg Jensen M; Nielsen JE; Juul A; Rajpert-De Meyts E J Steroid Biochem Mol Biol; 2013 Jul; 136():238-46. PubMed ID: 23098692 [TBL] [Abstract][Full Text] [Related]
12. Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine. Albany C; Hever-Jardine MP; von Herrmann KM; Yim CY; Tam J; Warzecha JM; Shin L; Bock SE; Curran BS; Chaudhry AS; Kim F; Sandusky GE; Taverna P; Freemantle SJ; Christensen BC; Einhorn LH; Spinella MJ Oncotarget; 2017 Jan; 8(2):2949-2959. PubMed ID: 27936464 [TBL] [Abstract][Full Text] [Related]
13. Influence of Nodal signalling on pluripotency factor expression, tumour cell proliferation and cisplatin-sensitivity in testicular germ cell tumours. Harpelunde Poulsen K; Nielsen JE; Grønkær Toft B; Joensen UN; Rasmussen LJ; Blomberg Jensen M; Mitchell RT; Juul A; Rajpert-De Meyts E; Jørgensen A BMC Cancer; 2020 Apr; 20(1):349. PubMed ID: 32326899 [TBL] [Abstract][Full Text] [Related]
14. Differential methylation EPIC analysis discloses cisplatin-resistance related hypermethylation and tumor-specific heterogeneity within matched primary and metastatic testicular germ cell tumor patient tissue samples. Lobo J; Constâncio V; Leite-Silva P; Guimarães R; Cantante M; Braga I; Maurício J; Looijenga LHJ; Henrique R; Jerónimo C Clin Epigenetics; 2021 Apr; 13(1):70. PubMed ID: 33823933 [TBL] [Abstract][Full Text] [Related]
15. Animacroxam, a Novel Dual-Mode Compound Targeting Histone Deacetylases and Cytoskeletal Integrity of Testicular Germ Cell Cancer Cells. Steinemann G; Dittmer A; Kuzyniak W; Hoffmann B; Schrader M; Schobert R; Biersack B; Nitzsche B; Höpfner M Mol Cancer Ther; 2017 Nov; 16(11):2364-2374. PubMed ID: 28838999 [TBL] [Abstract][Full Text] [Related]
16. Molecular Mechanisms of Cisplatin Chemoresistance and Its Circumventing in Testicular Germ Cell Tumors. Schmidtova S; Kalavska K; Kucerova L Curr Oncol Rep; 2018 Sep; 20(11):88. PubMed ID: 30259297 [TBL] [Abstract][Full Text] [Related]
17. High DNA methyltransferase 3B expression mediates 5-aza-deoxycytidine hypersensitivity in testicular germ cell tumors. Beyrouthy MJ; Garner KM; Hever MP; Freemantle SJ; Eastman A; Dmitrovsky E; Spinella MJ Cancer Res; 2009 Dec; 69(24):9360-6. PubMed ID: 19951990 [TBL] [Abstract][Full Text] [Related]
18. miRNA-302s may act as oncogenes in human testicular germ cell tumours. Das MK; Evensen HSF; Furu K; Haugen TB Sci Rep; 2019 Jun; 9(1):9189. PubMed ID: 31235829 [TBL] [Abstract][Full Text] [Related]
19. Role of MEK/ERK pathway in the MAD2-mediated cisplatin sensitivity in testicular germ cell tumour cells. Fung MK; Cheung HW; Ling MT; Cheung AL; Wong YC; Wang X Br J Cancer; 2006 Aug; 95(4):475-84. PubMed ID: 16880791 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of Mdm2 inhibition in malignant germ cell tumours. Bauer S; Mühlenberg T; Leahy M; Hoiczyk M; Gauler T; Schuler M; Looijenga L Eur Urol; 2010 Apr; 57(4):679-87. PubMed ID: 19560254 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]